The DOI matches its Crossref record.
Acute Hepatitis E Infection Accounts for Some Cases of Suspected Drug-Induced Liver Injury
Open accessAbstract
Background & Aims The diagnosis of drug-induced liver injury relies upon exclusion of other causes, including viral hepatitis A, B, and C. Hepatitis E virus (HEV) infection has been proposed as another cause of suspected drug-induced liver disease. We assessed the frequency of HEV infection among patients with drug-induced liver injury in the United States. Methods The drug-induced liver injury network (DILIN) is a prospective study of patients with suspected drug-induced liver injury; clinical information and biological samples are collected to investigate pathogenesis and disease progression. We analyzed serum samples, collected from patients enrolled in DILIN, for immunoglobulin (Ig)G and IgM against HEV; selected samples were tested for HEV RNA. Results Among 318 patients with suspected drug-induced liver injury, 50 (16%) tested positive for anti-HEV IgG and 9 (3%) for anti-HEV IgM. The samples that contained anti-HEV IgM (collected 2 to 24 weeks after onset of symptoms) included 4 that tested positive for HEV RNA, genotype 3. Samples from the 6-month follow-up visit were available from 4 patients; they were negative for anti-HEV IgM, but levels of anti-HEV IgG increased with time. Patients that had anti-HEV IgM were mostly from older men (89%; mean age, 67 years) and 2 were HIV positive. Clinical reassessment of the 9 patients with anti-HEV IgM indicated that acute hepatitis E was the most likely diagnosis for 7 and might be the primary diagnosis for 2. Conclusion HEV infection contributes to a small but important proportion of cases of acute liver injury that are suspected of being drug induced. Serologic testing for HEV infection should be performed—particularly if clinical features are compatible with acute viral hepatitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
Features and outcomes of 899 patients with drug-induced liver injury: the DILIN Prospective Study
Chalasani, N., Bonkovsky, H. L., Fontana, R., Lee, W., Stolz, A., Talwalkar, J., Reddy, K. R., Watkins, P. B., Navarro, V., Barnhart, H., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.006 · Cited by 925
Self-citationAndrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Self-citationACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury
Chalasani, N. P., Hayashi, P. H., Bonkovsky, H. L., Navarro, V. J., Lee, W. M., & Fontana, R. J. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.131 · Cited by 860
Self-citationRUCAM in Drug and Herb Induced Liver Injury: The Update
Danan, G., & Teschke, R. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms17010014 · Cited by 729
Drug-induced liver injury: recent advances in diagnosis and risk assessment
Kullak-Ublick, G. A., Andrade, R. J., Merz, M., End, P., Benesic, A., Gerbes, A. L., & Aithal, G. P. (2017) · Gut · doi:10.1136/gutjnl-2016-313369 · Cited by 438
ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
Chalasani, N. P., Maddur, H., Russo, M. W., Wong, R. J., Reddy, K. R., & on behalf of the Practice Parameters Committee of the American College of Gastroenterology (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001259 · Cited by 430
Self-citationLeise, M. D., Poterucha, J. J., & Talwalkar, J. A. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.09.016 · Cited by 356
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
Self-citationReview article: herbal and dietary supplement hepatotoxicity
Bunchorntavakul, C., & Reddy, K. R. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12109 · Cited by 249
Fontana, R. J., Hayashi, P. H., Gu, J., Reddy, K. R., Barnhart, H., Watkins, P. B., Serrano, J., Lee, W. M., Chalasani, N., Stolz, A., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.045 · Cited by 218
Self-citationHerbal hepatotoxicity: Clinical characteristics and listing compilation
Frenzel, C., & Teschke, R. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050588 · Cited by 122
Chalasani, N., Reddy, R. K. K., Fontana, R. J., Barnhart, H., Gu, J., Hayashi, P. H., Ahmad, J., Stolz, A., Navarro, V., & Hoofnagle, J. H. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.215 · Cited by 75
Self-citationDrug-induced liver injury: Highlights from a review of the 2015 literature
Sarges, P., Steinberg, J. M., & Lewis, J. H. (2016) · Drug Safety · doi:10.1007/s40264-016-0427-8 · Cited by 74
Wang, J., Ma, Z., Niu, M., Zhu, Y., Liang, Q., Zhao, Y., Song, J., Bai, Z., Zhang, Y., Zhang, P., et al. (2015) · Frontiers of Medicine · doi:10.1007/s11684-015-0417-8 · Cited by 70
Teschke, R., Wolff, A., Frenzel, C., Schwarzenboeck, A., Schulze, J., & Eickhoff, A. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i1.17 · Cited by 70
“Autoimmune(-Like)” drug and herb induced liver injury: new insights into molecular pathogenesis
Sebode, M., Schulz, L., & Lohse, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091954 · Cited by 47
Hepatic Damage by Natural Remedies
Medina-Caliz, I., Gonzalez-Jimenez, A., Garcia-Cortes, M., Lucena, M. I., & Andrade, R. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1623518 · Cited by 40
Dakhoul, L., Ghabril, M., Gu, J., Navarro, V., Chalasani, N., & Serrano, J. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.12.036 · Cited by 36
Self-citationThe honolulu liver disease cluster at the medical center: Its mysteries and challenges
Teschke, R., & Eickhoff, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040476 · Cited by 29
Teschke, R., Schwarzenboeck, A., Frenzel, C., Schulze, J., Eickhoff, A., & Wolff, A. (2016) · Annals of Hepatology · doi:10.5604/16652681.1184237 · Cited by 29
Huang, Y.-S., Chang, T.-T., Peng, C.-Y., Lo, G.-H., Hsu, C.-W., Hu, C.-T., & Huang, Y.-H. (2021) · Hepatology International · doi:10.1007/s12072-021-10241-3 · Cited by 17
Evidence of drug-induced hepatotoxicity in the Maghrebian population
Bourhia, M., Ullah, R., S. Alqahtani, A., & Ibenmoussa, S. (2022) · Drug and Chemical Toxicology · doi:10.1080/01480545.2020.1797088 · Cited by 16
Low prevalence of hepatitis E in Iceland: a seroepidemiological study
Löve, A., Björnsdottir, T. B., Olafsson, S., & Björnsson, E. S. (2018) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2017.1420218 · Cited by 15
Causality assessment methods in drug-induced liver injury
Teschke, R., & Danan, G. (2018) · Methods in Pharmacology and Toxicology · doi:10.1007/978-1-4939-7677-5_27 · Cited by 10
(2013) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2013.d002x · Cited by 10
Role of Hepatitis E Virus Infection in North American Patients With Severe Acute Liver Injury
Fontana, R. J., Engle, R. E., Gottfried, M., Hammed, B., Hanje, J., Durkalski, V., Kleiner, D. E., Nguyen, H., Nishimura, N., Lee, W. M., et al. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000273 · Cited by 9
Self-citation
Metadata
- Authors
- Davern, T. J., Chalasani, N., Fontana, R. J., Hayashi, P. H., Protiva, P., Kleiner, D. E., Engle, R. E., Nguyen, H., Emerson, S. U., Purcell, R. H., Tillmann, H. L., Gu, J., Serrano, J., & Hoofnagle, J. H.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 141
- Issue
- 5
- Pages
- 1665-1672.e9
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1967592761
- Cited by
- 328
- References
- 0
- FWCI
- 19.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.